Abstract Book - PDF - San Antonio Breast Cancer Symposium

CTRC-AACR San Antonio Breast Cancer Symposium
P3-01-03 Breast density profile in a prospective large breast cancer
screening program in South Brazil
Caleffi M, Zignani J, Clarissa A, Ademar BJ, Ribeiro R, Dakir DF. Núcleo
Mama Porto Alegre, Hospital Moinhos de Vento, Porto Alegre,
RS, Brazil.
P3-01-04 Surgical management of mammographic microcalcification is
improved by full field digital mammography (FFDM)
Bundred SM, Zhou J, Hurley E, Wilson M, Morris J, Bundred NJ.
University Hospital of South Manchester; University of Manchester.
P3-01-05 The Role of Mammographic Calcification in the Neo-adjuvant
Therapy of Breast Cancer Imaging Evaluation
Li JJ, Chen CM, Di GH, Wu J, Lu JS, Shao Z-M. Shanghai Cancer
Center and Cancer Institute, Shanghai, China.
P3-01-06 Ultrasound as single mode of imaging may miss significant
pathology in symptomatic women aged 35-39
Baker EL, Masudi T, Waterworth A. Calderdale and Huddersfield NHS
Foundation Trust, Huddersfield, West Yorkshire, United Kingdom.
P3-01-07 Estimated risk of radiation-induced breast cancer from
mammographic screening
Freitas-Junior R, Correa RS, Peixoto J-E, Ferreira RS, Tanaka RMN.
Federal University of Goias, Goiania, Goias, Brazil; Comissão Nacional
de Energia Nuclear, Goiania, Goias, Brazil; National Cancer Institute
of Brazil, Rio de Janeiro, RJ, Brazil; Superintendência de Vigilância em
Saúde do Estado de Goias, Goiania, Goias, Brazil.
P3-01-08 Mammographic density and estrogen receptor α gene
polymorphism in Javanese ethnic women
Choridah L, Aryandono T, Faisal A, Sadewa AH, Purnomosari D.
Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, DIY,
Indonesia; Faculty of Medicine, Universitas Gadjah Mada.
Detection/Diagnosis: Screening
P3-02-01 Mammographic Screening: Good Prognosis Tumor Biology in
Screen-detected Breast Cancers
Drukker CA, Schmidt MK, Rutgers EJT, Cardoso F, Kerlikowske
K, Esserman LJ, Slaets L, Bogaerts J, van’t Veer LJ. Netherlands
Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam,
Netherlands; Champalimaud Cancer Centre, Lisbon, Portugal;
University of California, San Francisco; EORTC, Brussels, Belgium;
Agendia NV, Amsterdam, Netherlands.
P3-02-02 Use of contrast-enhanced computed tomography in clinical
staging of asymptomatic breast cancer patients to detect
asymptomatic distant metastases
Tanaka S, Sato N, Fujioka H, Takahashi Y, Kimura K, Iwamoto M,
Uchiyama K. Osaka Medical College, Takatsuki City, Osaka, Japan.
P3-02-03 Increased risk of breast cancer in women with falsepositive
screening test: can it be entirely explained by
misclassification?
von Euler-Chelpin M, Kuchiki M, Vejborg I. University of Copenhagen,
Denmark; University Hospital Copenhagen, Denmark.
P3-02-04 Screen detected HER2 positive breast cancer within the
West of London Breast Screening population:Incidence,
Management and Outcome
O’Cathail S, White A, Brindley JH, Hadjiminas D, Xynos Y, Cleator
S, Hogben K, Palmieri C. Imperial College Healthcare NHS Trust,
London, United Kingdom.
P3-02-05 Subtypes of screen-detected invasive breast cancer and
symptomatic invasive breast cancer and their impact on
survival
Kobayashi N, Hikichi M, Miyajima S, Utsumi T. Fujita Health University,
Toyoake, Aichi, Japan.
P3-02-06
P3-02-07
P3-02-08
P3-02-09
P3-02-10
P3-02-11
P3-02-12
P3-02-13
Survival impact of early detection of recurrence after surgery
in early breast cancer patients
Hojo T, Tamura K, Masuda N, Inoue K, Kinoshita T, Fujisawa T, Hara
F, Saji S, Asaga S, Anan K, Yamamoto N, Wada N, Takahashi M,
Nakagami K, Kuroi K, Iwata H. National Cancer Center Hospital,
Tokyo, Japan; Osaka National Hospital, Osaka, Japan; Saitama Cancer
Center, Saitama, Japan; Gunma Prefectural Cancer Center, Gunma,
Japan; Shikoku Cancer Center, Shikoku, Japan; Kyoto University
Graduate School of Medicine, Kyoto, Japan; Kitakyushu Municipal
Medical Center, Kitakyushu, Japan; Chiba Cancer Center, Chiba,
Japan; National Cancer Center Hospital East, Chiba, Japan; Hokkaido
Cancer Center, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka,
Japan; Tokyo Metropolitan Cancer and Infectious diseases Center
Komagome Hospital, Tokyo, Japan; Aichi Cancer Center Hospital,
Nagoya, Aichi, Japan.
Rates of Cancer Detection and Abnormal Results among
Clients Recruited for Mammography through Outreach and
Education Supported by the Avon Breast Health Outreach
Program
Hurlbert M, Rose J, Opdyke KM, Gates-Ferris K. Cicatelli Associates
Inc. (CAI), New York, NY; Avon Foundation for Women, New York, NY.
Is repetition of the contralateral mammogram of patients
referred from breast cancer screening for unilateral findings
necessary?
Castro C, Schipper R-J, van Roozendaal L, van Goethem M, Lobbes
M, Smidt M. Maastricht University Medical Center, Maastricht,
Netherlands; Antwerp University Hospital, Antwerp, Belgium.
Cost-effectiveness of screening with additional MRI for
women with familial risk for breast cancer without a genetic
predisposition
Saadatmand S, Heijnsdijk EA, Rutgers EJ, Hoogerbrugge N,
Oosterwijk JC, Tollenaar RA, Hooning M, Obdeijn I-M, de Koning
HJ, Tilanus-Linthorst MM. Erasmus Medical Center, Rotterdam,
Netherlands; The Netherlands Cancer Institute, Antoni van
Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud
University Medical Center, Nijmegen, Netherlands; University Medical
Center Groningen, Netherlands; Leiden University Medical Center,
Leiden, Netherlands; Erasmus Medical Center, Netherlands.
Implementation and uptake of a provincial, population-based,
organized breast screening program for high risk women in
Ontario: The Ontario breast screening program (OBSP) high
risk program
Eisen A, Carroll J, Chiarelli AM, Horgan M, Meschino W, Rabeneck L,
Shumak R, Warner E. Sunnybrook Health Sciences Centre, Toronto,
ON, Canada; University of Toronto, ON, Canada; Mount Sinai Hospital,
Toronto, ON, Canada; Cancer Care Ontario, Toronto, ON, Canada;
North York General Hospital, Toronto, ON, Canada.
Screening Magnetic Resonance Imaging (MRI) of the breast
in women at increased lifetime risk for breast cancer: A
retrospective single institution study
Ehsani S, Strigel R, Pettke E, Wilke L, Szalkucki L, Tevaarwerk AJ,
Wisinski KB. University of Wisconsin Carbone Cancer Center,
Madison, WI.
The Cost of Mammography Screening in the United States by
Screening Policy
Thorsen CM, Eklund M, Ozanne EM, Esserman LJ. University of
California, San Francisco, CA; Karolinska Institute, Stockholm,
Sweden.
Analysis of infrastructure for mammography screening in the
State of Goias, Brazil, 2010
Freitas-Junior R, Correa RS, Peixoto J-E, Rodrigues DCN, Rahal RMS.
Federal University of Goias, Goiania, Goias, Brazil; Comissão Nacional
de Energia Nuclear, Goiania, Goias, Brazil; National Cancer Institute of
Brazil, Rio de Janeiro, RJ, Brazil.
Cancer Res; 72(24 Suppl.) December 15, 2012 34s Cancer Research